Abtak Logo

hepatology News

Stay updated with the latest hepatology news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on hepatology topics.

APN News - Health - News Image
soure image
29
HealthSep 26, 2025 10:05 AM

India's First Paediatric Liver Transplant for PFIC 13 Gives Eight-Year-Old New Life at Rainbow Child...

Chennai - Rainbow Children's Hospital, India's leading Paediatric multi-specialty and perinatal care hospital chain, has achieved a landmark in the nation's medical history by performing India's first live Paediatric liver transplant for Progressive Familial Intrahepatic Cholestasis Type 13 (PFIC 13). The procedure was carried out on an eight-year-old boy from Thoothukkudi at the hospital's state-of-the-art Center of Excellence for Paediatric Liver Transplant. Alongside this national first, the ...Read More >

Unknown Source - Business - News Image
source image
BusinessAug 14, 2025 10:51 AM

Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >

LatestLY - Business - News Image
soure image
14
BusinessAug 14, 2025 10:31 AM

Business News | Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide | ...

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. Also Read | 'Coolie' X Review: Rajinikanth's 'One-Man Show' With Nagarjuna's Stylish Act and Anirudh Rav ...Read More >

News Nation English - Politics Business - News Image
soure image
30
PoliticsBusinessAug 14, 2025 10:20 AM

Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >

The Times of India - Other Politics Sports Business Technology - News Image
soure image
15

ICMR invites EoIs for commercial production of advanced malaria vaccine

New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >

Rising Kashmir - Politics - News Image
soure image
9
PoliticsJul 20, 2025 12:22 AM

Making Waves: 36 Youngsters Celebrate Swimming Success at Nigeen Lake

Srinagar, July 19: In a heartwarming celebration of youth development and water safety, over 36 youngsters were awarded certificates and mementoes Saturday after successfully completing a basic swimming course at the scenic Water Sports Centre, Nigeen. The felicitation ceremony was led by Deputy Labour Commissioner (Central), Masrat Hashim.According to a statement issued here, the event formed part of a 100-day swimming initiative, spearheaded by the Swim N Survival Society-K in collaboration wi ...Read More >

Unknown Source - Health - News Image
source image
17
HealthJul 18, 2025 11:21 PM

Liver disease: Major medical breakthrough in capital hospital

NEW DELHI: In a major medical breakthrough, a city hospital has successfully performed the living donor liver transplant in combination with double heart valve surgery. The rare and high-risk procedure was conducted on a 55-year-old woman from Kyrgyzstan suffering from end-stage autoimmune liver disease and severe dysfunction in both the mitral and tricuspid heart valves. The patient, Anara M, sought treatment at Paras Health, Gurugram, on February 25, after years of hospitalisation. The pre-s ...Read More >

ThePrint - Other Sports Entertainment Health Business Politics - News Image
soure image
11

AIFF congratulates Inter Kashi on being crowned I-League 2024-25 champions

New Delhi, July 18 (SocialNews.XYZ) The All India Football Federation have congratulated Inter Kashi on being adjudged the I-League Champions following the decision by the Court of Arbitration for Sport (CAS). CAS has partially upheld an appeal by Inter Kashi Football Club (Inter Kashi FC) against Churchill Brothers FC Goa, Namdhari FC, Real Kashmir FC, and AIFF. CAS has ruled that the AIFF shall declare Inter Kashi FC as winners of the I-League 2024-25. After an unsuccessful first procedure i ...Read More >

Northern Ireland News - Health - News Image
soure image
16
HealthJul 18, 2025 06:38 PM

Gurugram hospital performs world's first living donor liver transplant with double heart valve surge...

Gurugram (Haryana) [India], July 18 (ANI): In a groundbreaking achievement for global medical care, Paras Health Gurugram, has successfully performed the world's first Living Donor Liver Transplant combined with a double heart valve surgery. This complex transplant was performed on a 55-year-old woman from Kyrgyzstan, who had been battling end-stage autoimmune liver disease along with severe valvular heart disease, said the hospital in a press release. The patient, Anara M, after multiple hosp ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.